133 related articles for article (PubMed ID: 32740071)
21. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
Cairoli E; Espinosa G
Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
[No Abstract] [Full Text] [Related]
22. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Patrì A; Fabbrocini G
J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
[No Abstract] [Full Text] [Related]
23. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
24. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
[No Abstract] [Full Text] [Related]
25. Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?
Regazzoni V; Loffi M; Garini A; Danzi GB
Circ J; 2020 Sep; 84(10):1887. PubMed ID: 32779609
[No Abstract] [Full Text] [Related]
26. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
[No Abstract] [Full Text] [Related]
27. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
[No Abstract] [Full Text] [Related]
28. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
29. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
30. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
31. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Tekwani BL
N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
[No Abstract] [Full Text] [Related]
32. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Khan MS; Butler J
N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
[No Abstract] [Full Text] [Related]
33. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Avidan MS; Dehbi HM; Delany-Moretlwe S
N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
[No Abstract] [Full Text] [Related]
34. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
Intson K; Kumar S; Botta A; Neckles R; Leung C; Jawaid A
Swiss Med Wkly; 2020 Apr; 150():w20262. PubMed ID: 32347963
[No Abstract] [Full Text] [Related]
35. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
Okafor EC; Pastick KA; Rajasingham R
N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
[No Abstract] [Full Text] [Related]
36. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Beauverd Y; Adam Y; Assouline B; Samii K
Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and Depression.
Shader RI
Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
39. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
Thomson K; Nachlis H
JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
[No Abstract] [Full Text] [Related]
40. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
